NASDAQ
No price data available for this timeframe.
Corcept Therapeutics Incorporated (CORT) has a free cash flow growth of -144.20% as of Friday, May 29, 2026. This represents a 185.26% decrease compared to its 12-month average of 169.14%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.